DEFA14A: AtriCure Urges Stockholders to Approve Say-on-Pay Proposal Despite Glass Lewis Recommendation

AtriCure is urging its stockholders to vote in favor of its Say-on-Pay proposal at the upcoming Annual Meeting, despite a recommendation against it from proxy advisory firm Glass Lewis.

Summary

• AtriCure has filed a supplement to its proxy statement to address concerns raised by Glass Lewis (GL) regarding its Say-on-Pay proposal.
• The company is urging stockholders to vote in favor of the proposal, highlighting Institutional Shareholder Services (ISS) support and their recommendation to vote for the proposal.
• AtriCure believes its compensation philosophy aligns executive pay with performance, internal equity, and fairness, designed to create long-term value for stockholders.
• The company argues that GL's analysis is flawed and based on a peer group that doesn't accurately reflect AtriCure's market peers.
• AtriCure emphasizes that a significant portion of executive pay is at risk and tied to multiple performance metrics, including revenue growth and gross margin.
• The Compensation Committee sets challenging target objectives and maintains double-trigger change in control agreements.
• The company highlights its 2023 performance, including revenue growth of 20.8% to $399.2 million and improved gross margin of 75.2%.
• Net loss improved by $16.0 million year over year to $30.4 million.
• AtriCure encourages stockholders to review the Proxy Statement and supplemental materials available at ir.atricure.com.

Sentiment

Score: 7

Explanation: The document conveys a moderately positive sentiment, emphasizing the company's growth, improved financial performance, and efforts to align executive compensation with stockholder interests. However, the negative recommendation from Glass Lewis introduces a note of caution.

Positives

• ISS supports AtriCure's Say-on-Pay proposal.
• A significant portion of executive compensation is performance-based.
• The company achieved substantial revenue growth in 2023.
• Gross margin improved in 2023.
• Net loss decreased year over year.

Negatives

• Glass Lewis recommends voting against the Say-on-Pay proposal.
• The company acknowledges that proxy advisory firms have raised concerns about change in control agreements in the past.

Risks

• Failure to secure stockholder approval for the Say-on-Pay proposal could lead to negative feedback and potential changes to the executive compensation program.
• Reliance on worldwide revenue growth as a key performance metric may not fully capture other important aspects of the business.

Future Outlook

The company aims to continue advancing strategic initiatives of product innovation, clinical science, and expanding physician awareness and adoption through superior training and education.

Management Comments

• The Compensation Committee believes our executive compensation program is well suited for AtriCure at this point in our growth and life-cycle.
• The Company believes that many of its current and prospective investors view worldwide revenue growth as the single most important performance metric of the Company.

Industry Context

The document highlights the increasing scrutiny of executive compensation by proxy advisory firms like Glass Lewis and ISS, and the importance of aligning executive pay with company performance and stockholder interests.

Comparison to Industry Standards

• The document mentions that Glass Lewis's standardized voting policies assess AtriCure's compensation program through the lens of a much more mature company than it currently is.
• The company believes that Glass Lewis's peer group does not truly reflect AtriCure's market peers.
• AtriCure's Compensation Committee has constructed its own peer group based on industry, revenue, business life cycle, and other pertinent criteria.

Stakeholder Impact

• Approval of the Say-on-Pay proposal would signal stockholder support for the company's executive compensation program.
• The company's performance and strategic initiatives impact shareholders, employees, customers, and other stakeholders.

Next Steps

• Stockholders are encouraged to vote on the Say-on-Pay proposal.
• The company will hold its Annual Meeting of Stockholders on May 13, 2024.

Key Dates

Keywords

Say-on-Pay, Executive Compensation, Proxy Statement, AtriCure, Stockholders, Revenue Growth, Gross Margin, ISS, Glass Lewis